As of 2026-02-04, the EV/EBITDA ratio of Pro Medicus Ltd (PME.AX) is 106.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PME.AX's latest enterprise value is 18,384.51 mil AUD. PME.AX's TTM EBITDA according to its financial statements is 172.48 mil AUD. Dividing these 2 quantities gives us the above PME.AX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 18.0x | 15.6x |
| Forward P/E multiples | 14.1x - 21.4x | 15.8x |
| Fair Price | 23.93 - 39.16 | 28.38 |
| Upside | -86.5% - -77.9% | -84.0% |
| Date | EV/EBITDA |
| 2026-02-03 | 106.90 |
| 2026-02-02 | 106.85 |
| 2026-01-30 | 110.81 |
| 2026-01-29 | 108.32 |
| 2026-01-28 | 112.00 |
| 2026-01-27 | 113.53 |
| 2026-01-23 | 108.50 |
| 2026-01-22 | 106.35 |
| 2026-01-21 | 107.18 |
| 2026-01-20 | 112.37 |
| 2026-01-19 | 113.89 |
| 2026-01-16 | 122.67 |
| 2026-01-15 | 124.18 |
| 2026-01-14 | 128.24 |
| 2026-01-13 | 126.06 |
| 2026-01-12 | 128.04 |
| 2026-01-09 | 126.63 |
| 2026-01-08 | 129.64 |
| 2026-01-07 | 129.27 |
| 2026-01-06 | 128.17 |
| 2026-01-05 | 129.65 |
| 2026-01-02 | 133.99 |
| 2025-12-31 | 133.10 |
| 2025-12-30 | 133.93 |
| 2025-12-29 | 134.34 |
| 2025-12-24 | 136.53 |
| 2025-12-23 | 139.78 |
| 2025-12-22 | 133.62 |
| 2025-12-19 | 131.10 |
| 2025-12-18 | 128.89 |
| 2025-12-17 | 131.56 |
| 2025-12-16 | 135.65 |
| 2025-12-15 | 140.86 |
| 2025-12-12 | 141.02 |
| 2025-12-11 | 140.17 |
| 2025-12-10 | 142.57 |
| 2025-12-09 | 149.38 |
| 2025-12-08 | 148.27 |
| 2025-12-05 | 150.55 |
| 2025-12-04 | 151.86 |
| 2025-12-03 | 153.41 |
| 2025-12-02 | 157.42 |
| 2025-12-01 | 157.15 |
| 2025-11-28 | 160.88 |
| 2025-11-27 | 160.45 |
| 2025-11-26 | 156.82 |
| 2025-11-25 | 157.28 |
| 2025-11-24 | 156.84 |
| 2025-11-21 | 151.44 |
| 2025-11-20 | 152.69 |